| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_390be8b40737dd62f57f366e17a9af5d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
1999-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9fdbe1a88d17b0cc4f9325d59fceab3 |
| publicationDate |
2000-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0010578-A1 |
| titleOfInvention |
STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| abstract |
Substantially purified stable human hypoxia-inducible factor-1α (sHIF-1alpha) proteins and polynucleotides encoding stable human hypoxia-inducible factor-1α proteins are provided. A method is provided for treating a hypoxia-related tissue damage in a subject by administering to the subject a therapeutically effective amount of an sHIF-1alpha protein or a nucleic acid encoding a stable HIF-1alpha protein. Formulations are provided for the administration of stable human hypoxia inducible factor-1α (HIF-1alpha) polypeptide or a polynucleotide encoding stable human hypoxia inducible factor-1alpha (HIF-1alpha) to a patient having or at risk of having hypoxia- or ischemia-related tissue damage. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6849718-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074980-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7361463-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02074980-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011046733-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6878729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016155804-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136616-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0136616-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005526010-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6660737-B2 |
| priorityDate |
1998-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |